Many people in Britain are experiencing a puzzling and severe skin condition that has confounded medical professionals. Sufferers report their skin becoming badly inflamed, cracked and flaking, often across their entire bodies, yet many doctors find it difficult to diagnose and treat the condition. The phenomenon, called topical steroid withdrawal (TSW) or red skin syndrome, has generated significant attention on social platforms, with videos documenting patients’ experiences garnering over a billion views on TikTok alone. Even though it impacts a growing number of people, TSW remains so inadequately understood that some doctors and dermatologists doubt whether it exists at all. Now, for the first time, researchers across the UK are commencing a major study to investigate what is responsible for these unexplained symptoms and how some people come to develop the condition whilst others do not.
The Puzzling Ailment Sweeping Across the UK
Bethany Gamble’s story exemplifies the severe consequences of topical steroid withdrawal on sufferers’ lives. The 21-year-old from Birmingham had managed her eczema effectively with steroid creams since childhood, but at eighteen, her condition worsened considerably. Her skin became intensely inflamed and red, cracking and oozing whilst the itching became what she characterises as “bone deep”. Within two years, the pain had become so severe that she was stuck in her bed, requiring round-the-clock care from her mother. Most concerning, Bethany experienced repeated dismissal by doctors who ascribed her symptoms to standard eczema and continued prescribing the very treatments she suspected were triggering her suffering.
The medical community continues to disagree on how to address TSW, with deep divisions about its basic nature. Some experts consider it a serious allergic reaction to the steroid-based creams that form the first-line treatment for eczema across the NHS. Others maintain it constitutes a severe flare-up of current skin conditions rather than a unique syndrome, whilst a small number are sceptical of its existence altogether. This professional uncertainty has placed patients like Bethany stuck in a diagnostic limbo, struggling to access proper treatment. The failure to reach consensus has encouraged Professor Sara Brown at the University of Edinburgh to set up the first major UK research project studying TSW, funded by the National Eczema Society.
- Symptoms comprise severe inflammation, cracking skin and persistent pruritus throughout the body
- Patients document “elephant skin” hardening and excessive flaking of keratinised cells
- Healthcare practitioners commonly disregard TSW as standard eczema or refuse to acknowledge it
- The condition may prove so incapacitating that sufferers become unable to carry out everyday tasks
Living with Topical Steroid Withdrawal
From Controllable Eczema to Disabling Symptoms
For numerous patients, topical steroid withdrawal represents a catastrophic deterioration from a previously stable skin condition. What starts with occasional itching in areas of skin fold can quickly progress into a full-body inflammatory response that renders patients incapable of functioning. The change typically happens suddenly, unexpectedly, converting a controllable long-term condition into an acute medical crisis. Patients report their skin becoming impossibly hot, red and inflamed, with severe cracking and weeping that requires constant attention. The bodily burden is worsened by fatigue, as the persistent itching prevents sleep and healing, establishing a vicious cycle of deterioration.
The pace at which TSW develops catches many sufferers by surprise. Those who have lived with eczema for years, sometimes decades, find themselves unprepared for the severity of symptoms that emerge when their condition rapidly deteriorates. Everyday tasks become overwhelming difficulties: showering becomes excruciating, dressing demands help, and maintaining personal hygiene demands considerable exertion. Some patients recount feeling as though their skin is being attacked from within, with inflammation moving through their body in patterns that bear little resemblance to their past episodes. This dramatic transformation often prompts sufferers to pursue immediate medical attention, only to meet with doubt from healthcare professionals.
The Fight for Recognition
Perhaps the most distressing aspect of topical steroid withdrawal is the dismissive medical responses that commonly occurs with it. Patients experiencing severe, unexplained symptoms are consistently informed they merely suffer from eczema flaring up, despite their insistence that this is essentially distinct from anything they’ve encountered previously. Doctors often respond by prescribing stronger steroids or increased doses, possibly exacerbating the very condition patients believe the creams caused. This pattern of rejection leaves sufferers feeling abandoned by the medical establishment, compelled to manage their illness alone whilst being told their lived experience is invalid. Many patients report feeling gaslit repeatedly, their worries disregarded as emotional or psychological in nature rather than actual physical health issues.
The absence of professional agreement has created a dangerous gap between what patients report and professional recognition. Without clear diagnostic criteria or defined treatment approaches, GPs and dermatologists find it difficult to diagnose TSW or provide suitable care. Some practitioners remain completely sceptical the disorder is real, treating all severe presentations as standard eczema or other known dermatological conditions. This professional uncertainty results in diagnostic delays, unsuitable therapies and profound psychological distress for people experiencing physical symptoms. The growing visibility of TSW on social media has drawn attention to this diagnostic void, encouraging investigation to investigate what thousands of people claim to be experiencing, even as the healthcare profession continues to disagree on how to respond.
- Signs may develop suddenly in individuals with previously stable eczema treated by topical steroids
- Patients often face scepticism from medical practitioners who attribute worsening to typical eczema exacerbations
- Healthcare providers remain divided on whether TSW is a real disorder or acute eczema flare-up
- Absence of diagnostic criteria means numerous patients struggle to access appropriate treatment and support
- Social media has magnified voices of patients, with TSW hashtags reaching more than one billion views worldwide
Racial Inequities in Diagnostic and Treatment Pathways
The diagnostic challenges surrounding TSW become even more pronounced amongst individuals with darker skin, where symptoms can be considerably more difficult to recognise visually. Redness and inflammation, the hallmark signs of TSW in lighter-skinned individuals, present distinctly across different ethnic groups, yet many assessment protocols remain focused on how the condition appears in white patients. This disparity means that individuals from Black, Asian and minority ethnic backgrounds experiencing TSW frequently encounter significantly extended timeframes in acknowledgement and confirmation. Healthcare professionals trained chiefly via appearances in lighter skin types may miss or misread the defining features, resulting in continued misidentification and incorrect management approaches that can exacerbate suffering.
Research into TSW has historically overlooked the lived experiences with deeper skin tones, perpetuating a cycle where their condition goes under-documented and under-studied. The online discussions shaping TSW discourse have been predominantly influenced by voices with lighter skin, potentially skewing medical understanding and community understanding. As Professor Sara Brown’s groundbreaking UK study progresses, ensuring diverse representation amongst research participants will be essential to developing truly inclusive diagnostic criteria and treatment approaches. Without intentional action to prioritise the perspectives of all ethnic groups, healthcare disparities in TSW identification and care risk widening further, abandoning at-risk communities without adequate support or answers.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Research and Treatment Solutions Developing
Leading UK Investigation Underway
Professor Sara Brown’s pioneering research at the Edinburgh University represents a turning point for TSW sufferers pursuing validation and understanding. With backing from the National Eczema Society, the study has recruited numerous participants across the UK to investigate the biological mechanisms underlying topical steroid withdrawal. By assessing symptoms, saliva samples and skin biopsies, researchers seek to identify why particular individuals experience TSW whilst others on identical steroid regimens do not. This scientific scrutiny marks a notable change from dismissal to serious investigation.
The study team collaborating with Dr Alice Burleigh from patient advocacy group Scratch That, brings both clinical knowledge and firsthand experience to the investigation. Their partnership approach recognises that patients hold essential understanding into their medical conditions. Professor Brown has noted patterns in TSW that cannot be accounted for by traditional understanding of eczema, including marked “elephant skin” thickening, extreme shedding and sharply demarcated areas of inflammation. The research findings could substantially alter how medical professionals manage diagnosis and treatment of this debilitating condition.
Available Treatments and Their Limitations
Presently, treatment options for TSW continue to be limited and commonly disappointing. Many clinicians continue prescribing topical steroids despite evidence indicating they could worsen symptoms in susceptible individuals. Some patients describe short-term improvement from emollients, antihistamines and systemic medications, though results vary widely. Dermatologists remain divided on optimal management strategies, with some advocating complete steroid cessation whilst others suggest slow reduction. This shortage of unified guidance sees patients managing their care journeys mostly in isolation, depending significantly on peer support networks and web-based forums for advice.
Psychological support and specialist dermatological care may provide advantages, yet access is inconsistent across the NHS. Some patients have investigated complementary methods including changes to diet, managing environmental factors and holistic therapies, though scientific evidence supporting these interventions remains sparse. The lack of established clinical protocols means treatment decisions often depend on individual dermatologist experience and patient preference rather than evidence-based guidelines. Until robust research produces definitive answers, TSW sufferers frequently describe feeling abandoned by conventional medicine.
- Emollient creams and hydrating products to enhance skin barrier function and minimise water loss
- Antihistamines to alleviate itching and related sleep disturbance in flare episodes
- Systemic corticosteroids or immune-suppressing agents for severe cases with specialist oversight
- Psychological counselling to tackle trauma and anxiety stemming from prolonged skin suffering
Voices of Hope and Determination
Despite the lack of clarity surrounding TSW and the frequently dismissive perspectives from medical practitioners, patients are gaining resilience in community and collective experience. Digital support communities have proven vital for those struggling with the disorder, providing validation and practical advice when traditional medicine has failed them. Many individuals affected describe the point at which they found the TSW hashtag as pivotal—finally finding others with the same symptoms and recognising they were not isolated in their experience. This collective voice has been powerful enough to spark the first serious research efforts, demonstrating that patient-led campaigns can advance medical understanding even when institutional structures stay unconvinced.
Bethany Gamble and people in similar situations are determined to draw attention and advocate for appropriate acknowledgement of TSW within the healthcare sector. Their openness in share deeply personal accounts of their challenges on social media has made discussions more commonplace around a disorder that many doctors still refuse to acknowledge. These people are not waiting passively for responses; they are engaging in research studies, recording their manifestations carefully, and demanding that their experiences be taken seriously. Their resilience in the confronting chronic suffering and invalidating medical treatment suggests possibility that solutions could become within grasp, and that those to come will obtain the acknowledgement and treatment they critically depend upon.
- Patient-led research initiatives are addressing shortcomings overlooked by traditional medical institutions and accelerating understanding of TSW
- Digital support networks offer psychological assistance, practical coping strategies, and peer validation for isolated sufferers globally
- Advocacy efforts are gradually shifting medical perception, prompting dermatologists to examine rather than dismiss individual accounts
